Literature DB >> 28027812

New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.

Marie Claire Van Hout1, Evelyn Hearne2.   

Abstract

BACKGROUND: The continual diversification of new psychoactive substances (NPS) circumventing legislation creates a public health and law enforcement challenge, and one particularly challenged by availability on Hidden Web cryptomarkets.
METHODS: This is the first study of its kind which aimed to explore and characterise cryptomarket forum members' views and perspectives on NPS vendors and products within the context of Hidden Web community dynamics. An internal site search was conducted on two cryptomarkets popular with NPS vendors and hosting fora; Alphabay and Valhalla, using the search terms of 40 popular NPS in the seven categories of stimulant/cathinone; GABA activating; hallucinogen, dissociative, cannabinoid, opioid and other/unspecified/uncategorised NPS. 852 identified threads relating to the discussion of these NPS were generated. Following exclusion of duplicates, 138 threads remained. The Empirical Phenomenological Psychological method of data analysis was applied. Four themes and 32 categories emerged.
RESULTS: 120 vendors selling NPS were visible on Alphabay, and 21 on Valhalla. Themes were 'NPS Cryptomarkets and Crypto-community interest in NPS'; 'Motives for NPS use'; 'Indigenous Crypto Community Harm Reduction'; and 'Cryptomarket Characteristics underpinning NPS trafficking', with two higher levels of abstraction centring on 'NPS vendor reputation' and 'NPS transactioning for personal use'. NPS cryptomarket characteristics centred on generation of trust, honesty and excellent service. Users appeared well informed, with harm reduction and vendor information exchange central to NPS market dynamics. GABA activating substances appeared most popular in terms of buyer interest on cryptomarkets. Interest in sourcing 'old favorite' stimulant and dissociative NPS was evident, alongside the sequential and concurrent poly use of NPS, and use of NPS with illicit drugs such as MDMA.
CONCLUSION: Continued monitoring of new trends in NPS within Surface Web and cryptomarkets are warranted. A particular focus on the rising market in prescribed benzodiazepine and Z-hypnotic drugs should be included.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cryptomarket; Hidden Web; Internet; New psychoactive substance

Mesh:

Substances:

Year:  2016        PMID: 28027812     DOI: 10.1016/j.drugpo.2016.11.007

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  17 in total

1.  Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017.

Authors:  Joseph J Palamar; Austin Le
Journal:  Hum Psychopharmacol       Date:  2019-03-06       Impact factor: 1.672

Review 2.  The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Authors:  Laura Orsolini; Stefania Chiappini; Duccio Papanti; Domenico De Berardis; John M Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2019-11-20       Impact factor: 4.157

Review 3.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

4.  Assessment of the abuse potential of methamnetamine in rodents: a behavioral pharmacology study.

Authors:  Dong-Hyun Youn; Jin Mook Kim; Young-Ki Hong; Seo-In Park; Jin-Moo Lee; Young-Hoon Kim; Chang Won Park; Mi Sun Kang
Journal:  Psychopharmacology (Berl)       Date:  2021-04-03       Impact factor: 4.530

5.  Risk management strategies of synthetic cannabis users.

Authors:  Stephanie Campos; Ellen Benoit; Eloise Dunlap
Journal:  Drugs Alcohol Today       Date:  2019-09-02

6.  Information sought, information shared: exploring performance and image enhancing drug user-facilitated harm reduction information in online forums.

Authors:  Boden Tighe; Matthew Dunn; Fiona H McKay; Timothy Piatkowski
Journal:  Harm Reduct J       Date:  2017-07-21

7.  Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries.

Authors:  Marie Claire Van Hout; Annemieke Benschop; Michal Bujalski; Katarzyna Dąbrowska; Zsolt Demetrovics; Katalin Felvinczi; Evelyn Hearne; Susana Henriques; Zsuzsa Kaló; Gerrit Kamphausen; Dirk Korf; Joana Paula Silva; Łukasz Wieczorek; Bernd Werse
Journal:  Int J Ment Health Addict       Date:  2017-12-07       Impact factor: 3.836

8.  New Psychoactive Substance 5-MeO-MiPT In vivo Acute Toxicity and Hystotoxicological Study.

Authors:  Yusuf Ali Altuncı; Melike Aydoğdu; Eda Açıkgöz; Ümmü Güven; Fahriye Düzağaç; Aslı Atasoy; Nebile Dağlıoğlu; Serap Annette Akgür
Journal:  Balkan Med J       Date:  2021-01       Impact factor: 2.021

9.  The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS.

Authors:  Elle Wadsworth; Colin Drummond; Paolo Deluca
Journal:  Brain Sci       Date:  2018-03-16

10.  Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK.

Authors:  Rosalind Gittins; Amira Guirguis; Fabrizio Schifano; Ian Maidment
Journal:  Brain Sci       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.